Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1902

1.

Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.

Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.

Am J Kidney Dis. 2003 Mar;41(3):539-49.

PMID:
12612976
2.

An index for renal outcome in ANCA-associated glomerulonephritis.

Vergunst CE, van Gurp E, Hagen EC, van Houwelingen HC, Hauer HA, Noël LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA, Bajema IM; EC/BCR Project for ANCA-Assay Standardisation.

Am J Kidney Dis. 2003 Mar;41(3):532-8.

PMID:
12612975
3.
4.

Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.

Geffriaud-Ricouard C, Noël LH, Chauveau D, Houhou S, Grünfeld JP, Lesavre P.

Clin Nephrol. 1993 Mar;39(3):125-36.

PMID:
7681736
8.
9.

In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.

Franssen CF, Huitema MG, Muller Kobold AC, Oost-Kort WW, Limburg PC, Tiebosch A, Stegeman CA, Kallenberg CG, Tervaert JW.

J Am Soc Nephrol. 1999 Jul;10(7):1506-15.

10.

Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis.

Neumann I, Regele H, Kain R, Birck R, Meisl FT.

Nephrol Dial Transplant. 2003 Mar;18(3):524-31.

PMID:
12584274
11.

Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.

Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M.

Arthritis Res Ther. 2005;7(5):R1072-81. Epub 2005 Jul 13.

13.

T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).

Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG.

Clin Exp Immunol. 1994 Dec;98(3):448-53.

14.

Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.

Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW.

Am J Kidney Dis. 2005 Aug;46(2):253-62. Review.

PMID:
16112043
15.

Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.

Chen M, Yu F, Wang SX, Zou WZ, Zhang Y, Zhao MH, Wang HY.

Nephrol Dial Transplant. 2007 Jan;22(1):139-45. Epub 2006 Sep 15.

PMID:
16980322
16.

ANCA-negative pauci-immune renal vasculitis: histology and outcome.

Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, Lesavre P, Noël LH.

Nephrol Dial Transplant. 2005 Jul;20(7):1392-9. Epub 2005 Apr 26.

PMID:
15855209
17.

[Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].

Arranz O, Ara J, Rodríguez R, Poveda R, Serra A, Solé-Amigó J, Fort J, Mirapeix E, Darnell A.

Nefrologia. 2001 Jul-Aug;21(4):349-54. Spanish.

18.

Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.

Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL.

Ann Intern Med. 1997 Jun 1;126(11):866-73.

PMID:
9163287
19.
20.

Antineutrophil cytoplasmic autoantibodies and associated diseases: a review.

Jennette JC, Falk RJ.

Am J Kidney Dis. 1990 Jun;15(6):517-29. Review.

PMID:
1973331

Supplemental Content

Support Center